 |
|
Events
SNBL CPC will be attending the following tradeshows in 2012:
- SCOPE Summit
Miami, Florida (February 7-9, 2012)
- Outsourcing in Clinical Trials - West Coast
Burlingame, CA (February 15-16, 2012)
- Partnerships in Clinical Trials
Orlando, FL (March 3-7, 2012)
- ASCPT
Washington, DC (March 14-17, 2012)
- Outsourcing in Clinical Trials - East Coast
Philadelphia, PA (March 27-28, 2012)
- World Vaccine Congress 2012
Washington, DC (April 10 - April 13, 2012)
- ACPU Annual Meeting
Bethesda, MD (April 26-27, 2012)
- Outsourcing in Clinical Trials - South East
TBD, NC (May 16-17, 2012)
- Bio International Convention
Washington, DC (June 18-21, 2012)
- DIA 2012
Philadelphia, PA (June 24-28, 2012)
- Outsourcing in Clinical Trials - New England
Boston, MA (September 19-20, 2012)
- ACCP (American College of Clinical Pharmacy)
Hollywood, FL (October 21-24, 2012)
- Outsourcing in Clinical Trials - Canada
(TBD)
- Vaccine Business Congress
Baltimore, MD (November 1, 2012)
- Mid-Atlantic Bio
Washington, DC (TBD)
Press Releases
-
New Laboratory Capabilities [12/9/2011] -NEW!-
SNBL Clinical Pharmacology Center, Inc. (SNBL-CPC) in Baltimore, MD has upgraded its accreditation and onsite clinical laboratory capabilities to perform moderate to high complexity test procedures. The SNBL lab team under the leadership of John Seiple, Lab Director at SNBL-CPC has obtained laboratory licensing from the State of Maryland, and has become COLA and CLIA certified. The certifications will permit SNBL-CPC to offer a larger range of clinical safety laboratory testing to its clients.
-
Dr. Rudin appointed as Medical Director [12/8/2011] -NEW!-
Dan Rudin, MD has joined SNBL-CPC as Medical Director. Dr. Rudin will be directing the day to day clinical operations, and providing strategic medical input to our sponsors and internal team regarding clinical trial feasibility, design and execution. Dr. Rudin will also be serving as SNBL's primary principle investigator for numerous clinical trials.
-
Patrick Ayd appointed as Chief Operating Officer [12/8/2011] -NEW!-
Baltimore, MD, December 8th, 2011: SNBL-CPC one of the nation's leading CRO dedicated to Phase I & IIa clinical research is pleased to announce new executive leadership with the arrival of Patrick R. Ayd as Chief Operating Officer (COO). As COO, Mr. Ayd will have overall responsibility managing SNBL-CPC's clinical, administrative, and business development departments and optimizing the SNBL-CPC research platform to perform enhanced Phase I/IIa clinical trials of the highest quality for a wide variety of industry sponsors who require the utmost level of quality and white glove service when executing their Early Phase clinical trials.
-
SNBL is the proud recipient of the 13th Annual Maryland International Business Leadership Award. Our President, Dr. Mohamed Al-Ibrahim accepted
this award on SNBL's behalf as a business global leader based in the state of Maryland. [3/12/2009]
"I am delighted that the World Trade Center Institute
has chosen Mohamed Al-Ibrahim as its International Business Leader of the Year. Under Dr. Al-Ibrahim's leadership, SNBL-CPC has greatly expanded
its workforce and operations in the UMB BioPark and strengthened the Baltimore region's global outreach." -- David J. Ramsay,
President University of Maryland, Baltimore
-
SNBL CPC opens at UMB BioPark [10/18/2005]
What's New
- Ophthalmologic services on-site - Equipment and clinical staff available
- A strategic focus on Vaccine Development to strengthen our comprehensive services
Related Articles
|
|
|
|
Print